China Pharma Holdings (CPHI) Non-Current Assets (2010 - 2026)

China Pharma Holdings has reported Non-Current Assets for 17 years, with the latest figure at $43.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 279.55% year-over-year to $43.1 million; the trailing twelve-month figure through Mar 2026 stood at $96.3 million (up 124.04% YoY), and the FY2025 full-year result was $28.7 million, up 146.64% from the prior year.
• Non-Current Assets for Q1 2026 stood at $43.1 million, up from $28.7 million in the prior quarter.
• The five-year high for Non-Current Assets was $43.1 million in Q1 2026, with the low at $9.5 million in Q3 2023.
• Historically, Non-Current Assets has averaged $14.0 million across 5 years, with a median of $11.3 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Assets dropped 24.53% — and 2026, when it soared 279.55%.
• China Pharma Holdings' Non-Current Assets stood at $11.8 million in 2022, then declined by 11.4% to $10.5 million in 2023, then climbed by 10.93% to $11.6 million in 2024, then jumped by 146.64% to $28.7 million in 2025, then soared by 50.56% to $43.1 million in 2026.
• The last three Non-Current Assets figures came in at $43.1 million (Q1 2026), $28.7 million (Q4 2025), and $13.5 million (Q3 2025), per Business Quant data.